Transdermal iontophoretic delivery of ketoprofen through human cadaver skin and in humans

Journal of Controlled Release

Volumn 44, Issue 2-3, 1997, Pages 113-121

  Panus, Peter C ^a   Campbell, Jennifer ^b   Kulkarni, Shirishkumar B ^b   Herrick, Richard T ^c   Ravis, William R ^b   Banga, Ajay K ^b  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

^c Herrick Clin and Ctr for Adv O   (United States)

Author keywords

human study; iontophoresis; ketoprofen; stereoselectivity; transdermal

Indexed keywords

ANTIINFLAMMATORY AGENT; KETOPROFEN;

ARTICLE; CADAVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG BLOOD LEVEL; ELECTRODE; ENANTIOMER; FOREARM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IONTOPHORESIS; NORMAL HUMAN; PRIORITY JOURNAL; SKIN PENETRATION; STEREOSPECIFICITY; TRANSDERMAL DRUG ADMINISTRATION; URINARY EXCRETION; VENOUS BLOOD; VOLUNTEER; WRIST;

EID: 0031575547     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01509-X     Document Type: Article

References (27)

1. G.K. McEvoy (Ed.), AHFS Drug Information, American Society of Hospital Pharmacists, Bethesda, MD, 1994, p. 1246.
2. F. Jamali and D.R. Brocks, Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin. Pharmacokinet. 19 (1990) 197-217.
3. S.D. Roy and E. Manoukian, Permeability of ketorolac acid and its ester analogs (prodrug) through human cadaver skim. J. Pharm. Sci. 83 (1994) 1548-1553.
4. S.D. Roy, E. Manoukian and D. Combs, Absorption of transdermally delivered ketorolac acid in humans. J. Pharm. Sci. 84 (1995) 49-52.
5. S. Santoyo, A. Arellano, P. Ygartua and C. Martin, Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int. J. Pharm. 117 (1995) 219-224.
6. H. Pratzel, P. Dittrich and W. Kukovetz, Spontaneous and forced cutaneous absorption of indomethacin in pigs and humans. J. Rheumatol. 13 (1986) 1122-1125.
7. L.V. Allen, Ketoprofen gel. US Pharmacist Nov. (1993) 98-100.
8. S. Chi and H.W. Jun, Anti-inflammatory activity of ketoprofen gel on carrageenan-induced rat paw edema in rats. J. Pharm. Sci. 79 (1990) 974-977.
9. R. Ballerini, A. Casini, M. Chinol, C. Mannucci, L. Giaccai and M. Salvi, Study on the absorption of ketoprofen topically administered in man: comparison between tissue and plasma levels. Int. J. Clin. Pharm. Res. 6 (1986) 69-72.
10. M. Matucci-Cerinic and A. Casini, Ketoprofen vs etofenamate in a controlled double-blind study: evidence of topical effectiveness in soft tissue rheumatic pain. Int. J. Clin. Pharm. Res. 8 (1988) 157-160.
11. N. Ohara, K. Takayama, Y. Machida and T. Nagai, Combined effect of D-limonene and temperature on the skin permeation of ketoprofen. Int. J. Pharm. 105 (1994) 31-38.
12. B. Flouvat, A. Roux and B. Delhotal-Landes, Pharmacokinetics of ketoprofen in man after repeated percutaneous administration. Arzneim. Forsch. Drug Res. 39 (1989) 812-815.
13. R.H. Bogner and A.K. Banga, Iontophoresis and phonophoresis. US Pharmacist 19 (1994) H10-H26.
14. B.R. Meyer, W. Kreis and J. Eschbach, Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin. Pharmacol. Ther. 44 (1988) 607-612.
15. M.A. Ashburn, J. Streisand, J. Zhang, G. Love, M. Rowin, S. Niu, J.K. Kievit, J.R. Kroep and M.J. Mertens, The iontophoresis of fentanyl citrate in humans. Anesthesiology 82 (1995) 1146-1153.
16. J.M. Glass, R.L. Stephen and S.C. Jacobson, The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis. Int. J. Dermatol. 19 (1980) 519-525.
17. L.E. Bertolucci, Introduction of antiinflammatory drugs by iontophoresis: double blind study. J. Orthop. Sports Phys. Ther. 4 (1982) 103-108.
18. A. Chantraine, J.P. Ludy and D. Berger, Is cortisone iontophoresis possible? Arch. Phys. Med. Rehabil. 67 (1986) 38-40.
19. T.J. Petelenz, J.A. Buttke, C. Bonds, L.B. Lloyd, J.E. Beck, R.L. Stephen, S.C. Jacobsen and P. Rodriguez, Iontophoresis of dexamethasone: laboratory studies. J. Cont. Rel. 20 (1992) 55-66.
20. L. Salli, Attivita e tollerabilita del ketoprofene somministrato per jonoforesi nella patologia artroreumatica: risultati di uno studio policentrico. Clin. Ter. 142 (1993) 533-537.
21. M.R. Wright and F. Jamali, Limited extent of stereochemical conversion of chiral non-steroidal anti-inflammatory drugs induced by derivatization methods employing ethyl chloroformate. J. Chromatogr. 616 (1993) 59-65.
22. P.C. Panus, S.A. Wright, P.H. Chumley, R. Radi and B.A. Freeman, The contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen mediated cell injury. Arch. Biochem. Biophys. 294 (1992) 695-702.
23. A.K. Banga and Y.W. Chien, Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J. Controlled Rel. 7 (1988) 1-24.
24. S. Thysman and V. Preat, In vivo iontophoresis of fentanyl and sufentanil in rats: pharmacokinetics and acute antinociceptive effects. Anesth. Analg. 77 (1993) 61-66.
25. A. Kim, P.G. Green, G. Rao and R.H. Guy, Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10 (1993) 1315-1320.
26. E.R. Scott, A.I. Laplaza, H.S. White and J.B. Phipps, Transport of ionic species in skin: contribution of pores to the overall skin conductance. Pharm. Res. 10 (1993) 1699-1709.
27. T.K. Ghosh and A.K. Banga, Methods of enhancement of transdermal drug delivery. Part IIA. Chemical permeation enhancers. Pharm. Technol. 17 (4) (1993) 62-90.